FAQs
The Mika app is a digital assistant that offers personalized guidance and support for adults going through cancer.
The app has been proven in clinical studies to reduce the psychological distress, depression, anxiety, and fatigue associated with cancer treatment. Users can track their physical and mental symptoms and explore programs that include physical exercises, nutritional advice, and guided mental health journeys.
Our content is developed in cooperation with leading oncological research institutes and tumor centers including Berlin Charité and Leipzig University Hospital.
Cancer is a huge challenge, both physically and mentally. With Mika, you can take an active role in driving your recovery between oncology appointments.
Our content is developed with expert psycho-oncologists and offers you a range of ways to engage in proactive self-care as you progress through treatment.
With Mika, you can:
- Get reliable information about your condition. All our articles are grounded in proven medical facts.
- Optimize your nutrition and physical fitness to support better overall wellbeing.
- Track your symptoms so you (and your healthcare provider, if you choose to share) can better understand how you’re responding to treatment.
- Get empathetic mental health support and guided exercises to help you through the toughest days.
Mika is free for you forever. We do not take any money from people affected by cancer.
Your personal information and data is always safe and is never disclosed to third parties.
Mika works with external partners to optimize the patient experience and drive better health outcomes. We provide life science collaborators and healthcare providers with aggregated data insights that inform how they develop and administer treatments.
Yes. At Mika, we are 100% committed to handling your data responsibly.
Health data is highly sensitive so we implement the strictest security measures as a matter of course. Mika is fully compliant with GDPR, CCPA, and HIPAA data security standards and our ISMS (information security management systems) has an ISO 27001 certification.
Mika is a certified medical device in accordance with the German Medical Devices Act. To attain this certification, we are required to meet extremely stringent data security standards.
You can download the Mika app to your smartphone via the Apple App Store or the Google Play Store. You can find more information here.
The Mika team strives to continuously develop the app based on the latest research and highest scientific standards. That’s why we collaborate with various institutions on research, information gathering, and mutual support with the goal of providing the best possible digital therapeutic to cancer patients.
Current and former partners are:
- National Decade Against Cancer
- Charité Hospital in Berlin
- NCT Heidelberg
- University Cancer Center Leipzig
- University Hospital Düsseldorf (University Tumor Center)
- National Center for Tumor Diseases Dresden
- University Tumor Center Jena
- Saarland Cancer Society
- AstraZeneca
- Recordati Rare Diseases
- Novartis
Collaborations with research-based pharmaceutical companies primarily benefits patients who rely on medications from these manufacturers. Through their individual access code, they receive a personalized experience linked to their medication, indcluding symptom and side effect management, and more content tailored to where they are in their treatment journey. This information is provided in a separate, private area of the Mika app. These collaborations enable Mika to offer a more personalized experience to patients.
There is no advertising in the app. Neither pharmaceutical companies nor specific medications are highlighted in favorable ways. Information about individual medications is provided to users only after a prescription by an independent doctor.
Mika also offers simple and uncomplicated therapy support, for example through medication reminders and a symptom diary. With the Mika app, cancer patients also have the opportunity to further improve their treatment by voluntarily consenting to the use of their data by research companies. With data from patients, manufacturers can recommend specific dosages on an individual level in the future to achieve better therapy results with fewer side effects.
